(Q38334166)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

2 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Transactivation of the EGR1 gene contributes to mutant p53 gain of function (English)

1 reference

2 September 2017

7

Varda Rotter

1 reference

2 September 2017

Lilach Weisz

1

1 reference

2 September 2017

Amir Zalcenstein

2

1 reference

2 September 2017

Perry Stambolsky

3

1 reference

2 September 2017

Yehudit Cohen

4

1 reference

2 September 2017

Naomi Goldfinger

5

1 reference

2 September 2017

Moshe Oren

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

2 September 2017

1 reference

2 September 2017

64

1 reference

2 September 2017

8318-8327

1 reference

2 September 2017

22

1 reference

The dual role model for p53 in maintaining genomic integrity

2 September 2017

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Early growth response-1-dependent apoptosis is mediated by p53.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Chemosensitivity linked to p73 function

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Molecular epidemiology of human cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Different tumor-derived p53 mutants exhibit distinct biological activities

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

EGR1 target genes in prostate carcinoma cells identified by microarray analysis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Impaired prostate tumorigenesis in Egr1-deficient mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Regulation of life and death by the zinc finger transcription factor Egr-1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Egr-1: is it always immediate and early?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Gain of function mutations in p53.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Egr-1-induced endothelial gene expression: a common theme in vascular injury

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Mutant p53 protein expression interferes with p53-independent apoptotic pathways.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-04-1145

Identifiers

DOI

10.1158/0008-5472.CAN-04-1145

1 reference

2 September 2017

1 reference